Ripretinib for advanced gastrointestinal stromal tumours – Authors' reply

Jean Yves Blay; Margaret von Mehren

doi:10.1016/S1470-2045(20)30479-4

Ripretinib for advanced gastrointestinal stromal tumours – Authors' reply

Research output: Contribution to journal › Letter › peer-review

2 Scopus citations

Original language	English
Pages (from-to)	e415
Journal	The Lancet Oncology
Volume	21
Issue number	9
DOIs	https://doi.org/10.1016/S1470-2045(20)30479-4
State	Published - Sep 2020

Access to Document

10.1016/S1470-2045(20)30479-4

Cite this

@article{4dce4ede7ded4e7daa1d9c72f34f0c0e,

title = "Ripretinib for advanced gastrointestinal stromal tumours – Authors' reply",

author = "Blay, {Jean Yves} and {von Mehren}, Margaret",

year = "2020",

month = sep,

doi = "10.1016/S1470-2045(20)30479-4",

language = "English",

volume = "21",

pages = "e415",

journal = "The Lancet Oncology",

issn = "1470-2045",

publisher = "Elsevier Ltd.",

number = "9",

}

TY - JOUR

T1 - Ripretinib for advanced gastrointestinal stromal tumours – Authors' reply

AU - Blay, Jean Yves

AU - von Mehren, Margaret

PY - 2020/9

Y1 - 2020/9

UR - http://www.scopus.com/inward/record.url?scp=85089948374&partnerID=8YFLogxK

UR - https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=purepublist2023&SrcAuth=WosAPI&KeyUT=WOS:000568490900010&DestLinkType=FullRecord&DestApp=WOS

U2 - 10.1016/S1470-2045(20)30479-4

DO - 10.1016/S1470-2045(20)30479-4

M3 - Letter

C2 - 32888465

SN - 1470-2045

VL - 21

SP - e415

JO - The Lancet Oncology

JF - The Lancet Oncology

IS - 9

ER -

Ripretinib for advanced gastrointestinal stromal tumours – Authors' reply

Access to Document

Other files and links

Fingerprint

Cite this